Study comparing HPV vaccine immune response in 13-14 year olds
Part of Infections clinical trials.
This study checks how well two types of domestic HPV vaccines and one imported HPV vaccine boost your immune system. It is for girls aged 13-14 who have already finished their HPV vaccine shots about a month ago.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 13 or 14 years old and have completed all doses of a specific HPV vaccine (either domestic bivalent or imported) 30 to 60 days ago.
- You and your parent or guardian can provide legal ID and sign a consent form.
- You are willing to come for follow-up visits and give blood samples.
- You have not received any other HPV vaccine or participated in other HPV vaccine studies.
- You do not have serious health problems like a weakened immune system, autoimmune disease, epilepsy, or blood clotting issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a 9-valent HPV vaccine (protects against 9 types of human papillomavirus) in women who have already completed a previous HPV vaccine series. Researchers will check how safe the new vaccine is and how well your immune system responds to it.
This study compares how well your immune system responds to an HPV vaccine given as either 2 doses or 3 doses in people ages 27–45 who have never had the HPV vaccine. It may help improve HPV prevention strategies and guide the best dose schedule for adults.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
This study checks if one dose of the 9-valent HPV vaccine given at ages 9-11 still protects you 6 years later. It is for people who only had that single dose and no other HPV shots.
This trial tests if a single dose of a locally made HPV vaccine (CERVAVAC) works as well as a single dose of the standard Gardasil vaccine. It is for girls and young women aged 9 to 20, and boys aged 9 to 14, in Zambia. The goal is to prevent HPV infection, which can cause cervical cancer.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.